GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Regencell Bioscience Holdings Ltd (NAS:RGC) » Definitions » Marketable Securities

RGC (Regencell Bioscience Holdings) Marketable Securities : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Regencell Bioscience Holdings Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Regencell Bioscience Holdings's Marketable Securities for the quarter that ended in Dec. 2024 was $0.00 Mil.

Regencell Bioscience Holdings's annual Marketable Securities stayed the same from Jun. 2022 ($10.00 Mil) to Jun. 2023 ($10.00 Mil) but then declined from Jun. 2023 ($10.00 Mil) to Jun. 2024 ($5.00 Mil).


Regencell Bioscience Holdings Marketable Securities Historical Data

The historical data trend for Regencell Bioscience Holdings's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regencell Bioscience Holdings Marketable Securities Chart

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Marketable Securities
Get a 7-Day Free Trial - - 10.00 10.00 5.00

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 10.00 - 5.00 -

Regencell Bioscience Holdings Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Regencell Bioscience Holdings  (NAS:RGC) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Regencell Bioscience Holdings Marketable Securities Related Terms

Thank you for viewing the detailed overview of Regencell Bioscience Holdings's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Regencell Bioscience Holdings Business Description

Traded in Other Exchanges
N/A
Address
29 Leighton Road, 9/F Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.